A practical reference on TB-500: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-29. Anything still debated is marked as such rather than presented as settled.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Discussion of the compound frequently appears alongside other short peptides described as fragments of larger proteins. That grouping is convenient but can be misleading, because fragment length, charge, and modification state determine how a peptide behaves in solution and in any experimental system. A seven-residue acetylated peptide and a full-length protein differ in mass by roughly an order of magnitude, and they cannot be assumed to share distribution or binding properties. Precision about which molecule is under discussion is the single most useful step when reading such material.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
These N-methyltryptamines are much more lipophilic than serotonin and, in contrast, are able to diffuse into serotonergic neurons and activate intracellular serotonin 5-HT2A receptors. Another metabolite of serotonin with possible psychedelic-like effects in animals is 5-methoxytryptamine (5-MT). DMT is a naturally occurring endogenous compound in the body. In relation to the fact that serotonin itself is unable to activate intracellular serotonin 5-HT2A receptors, it is possible that DMT might be the endogenous ligand of these receptors rather than serotonin.
The historically significant Phytophthora infestans, the cause of late blight, remains an ongoing problem in Europe and the United States. Other potato diseases include Rhizoctonia, Sclerotinia, Pectobacterium carotovorum (black leg), powdery mildew, powdery scab and leafroll virus. Insects that commonly transmit potato diseases or damage the plants include the Colorado potato beetle, the potato tuber moth, the green peach aphid (Myzus persicae), the potato aphid, Tuta absoluta, beet leafhoppers, thrips, and mites. The Colorado potato beetle is considered the most important insect defoliator of potatoes, devastating entire crops. The potato cyst nematode is a microscopic worm that feeds on the roots, thus causing the potato plants to wilt. Since its eggs can survive in the soil for several years, crop rotation is recommended.
In May 2015, the company announced the closure of its U.S. headquarters in Dublin, Ohio; in March 2015, it had 127 employees. In August 2016, Tim Hortons again changed presidents. In September 2016, Tim Hortons announced it would be expanding into the United Kingdom, with an unannounced number of locations to be built. Revenue in 2015 for Restaurant Brands International was US$4.0522 billion with a rise to $4.15 billion in 2016. Tim Hortons had 683 U.S. locations by the end of 2016, and total annual revenue of US$3.00 billion. In April 2018, Tim Hortons announced that they would be moving their head office along with its 400 employees to the Exchange Tower in downtown Toronto. In May 2018, the Reputation Institute reported that Tim Hortons had fallen from 13th to 67th in its study of Canada's most reputable companies, as "one of the largest moves down of all 250 companies it analyzed this year'" and that the brand was "still considered to have a 'strong reputation.'" In October 2018, Tim Hortons began to install self-serve kiosks at some locations in Ontario. In February 2019, Tim Hortons began to spread the installation of the self-serve kiosks across Canada.
In a water molecule, the hydrogen atoms form a 104.5° angle with the oxygen atom. The hydrogen atoms are close to two corners of a tetrahedron centered on the oxygen. At the other two corners are lone pairs of valence electrons that do not participate in the bonding. In a perfect tetrahedron, the atoms would form a 109.5° angle, but the repulsion between the lone pairs is greater than the repulsion between the hydrogen atoms. The O–H bond length is about 0.096 nm. Other substances have a tetrahedral molecular structure, for example methane (CH4) and hydrogen sulfide (H2S). However, oxygen is more electronegative than most other elements, so the oxygen atom has a negative partial charge while the hydrogen atoms are partially positively charged. Along with the bent structure, this gives the molecule an electrical dipole moment and it is classified as a polar molecule. Water is a good polar solvent, dissolving many salts and hydrophilic organic molecules such as sugars and simple alcohols such as ethanol. Water also dissolves many gases, such as oxygen and carbon dioxide – the latter giving the fizz of carbonated beverages, sparkling wines and beers. In addition, many substances in living organisms, such as proteins, DNA and polysaccharides, are dissolved in water. The interactions between water and the subunits of these biomacromolecules shape protein folding, DNA base pairing, and other phenomena crucial to life (hydrophobic effect). Many organic substances (such as fats and oils and alkanes) are hydrophobic, that is, insoluble in water.
== Structure == PnuC of Salmonella typhimurium and Haemophilus influenzae are integral membrane proteins, 239 and 226 amino acyl residues (aas) in length, respectively, with 7 putative transmembrane α-helical segments. The structure of NadR has been determined. Mutations in the nadR gene which interfere with NR uptake occur in the C-terminal part of NadR. A helix-turn-helix DNA binding domain present in NadR of S. enterica serovar Typhimurium could not be found in the NadR homologue of H. influenzae. Therefore, it was proposed that in H. influenzae NadR has no regulatory function at the transcriptional level. The structures of the human NR kinase 1 (2QL6_P) with nucleotide and nucleoside substrates bound have been solved. It is structurally similar to Rossmann fold metabolite kinases. PnuC has been shown to resemble SWEET porters in overall fold, supporting the conclusion that these two families are members of the TOG superfamily.
Sources: en.wikipedia.org
tight junction Also occluding junction or zonula occludens. A type of specialized intercellular junction characterized by very close contact between the plasma membranes of adjacent cells, which are held together by large multiprotein complexes that completely or nearly completely occlude the passage of water and solutes through the intercellular space between cells. Tight junctions occur in many vertebrate tissues, especially between the epithelial and endothelial cells that line the surfaces of most organs and vessels. These cells are completely encircled by tight junctions which create a gasket-like seal that separates each cell's plasma membrane into apical and basolateral domains and prevents the exchange of extracellular materials between them.
He began his campaign by defeating home favourite Matteo Berrettini who retired with an injury. On his way to the title he defeated the top two seeds Djokovic and Medvedev in the semifinals and finals respectively. Due to this win, he became the only player active to have won multiple ATP Finals titles (2) other than Djokovic and Roger Federer, with 7 and 6, respectively.
== Background == Even before the April 1775 Battles of Lexington and Concord in Massachusetts, both the Americans and British knew that passage on the Hudson River was strategically important to each sides’ war effort. The Americans were desperate to control the river, lest New England be divided from the rest of the colonies. The immediate American plan was to slow or block ship traffic on the river by attacking British vessels with cannon and mortars from both shores. This anticipated batteries at both existing and planned defensive fortifications. In late 1776 Henry Wisner, a resident of Goshen, New York, and one of New York's representatives to the Continental Congress, along with Gilbert Livingston, sounded the Hudson River and, as part of a Secret Committee of the "Committee of Safety," recommended the placement of chains in strategic locations along the Hudson. Colonial forces eventually constructed three obstacles across the river: a chevaux-de-frise at northern Manhattan between Forts Washington and Lee in 1776; at the lower entrance to the Hudson Highlands, from newly constructed Fort Montgomery on the west bank at Popolopen Creek just north of the modern-day Bear Mountain Bridge to Anthony's Nose on the east bank in 1776–1777; and between West Point and Constitution Island in 1778, known as the Great Chain. A fourth, a cheval-de-frise started in 1776 between Plum Point on the east bank and Pollepel Island north of West Point, was begun but abandoned.
Emdogain which has been shown to significantly improve probing attachment levels (1.1mm) and periodontal pocket depth reduction (0.9mm) when compared to a placebo or control materials. Resorption rates ranging from six to 24 weeks depending on its different chemical structures. With the resorbable membrane used, the membrane will bio-degrade. There is no need for a second surgery to remove the membrane, this will prevent any disruption to the healing process of the regenerated tissues. A synthetic resorbable membrane (eg: Powerbone Barrier Membrane) is an ideal alternative to the resorbable collagen material. Randomised clinical trials compared the stability of augmented bone between a synthetic resorbable membrane and a collagen membrane with guided bone regeneration simultaneous to dental implant placement in the aesthetic zone in terms of facial bone thickness. Success depends on several factors: osteoblasts being present at the site, a sufficient blood supply, stabilisation of the graft during healing, and soft tissue not being under tension.
== Cultivation == The sacred lotus grows in water about 2.5 m (8 ft) to 30 cm (12 in) deep. In colder climates, a deeper water level protects the tubers more effectively, and improves growth and flowering. The sacred lotus germinates at temperatures above 13 °C (55 °F). Most varieties are not naturally cold-hardy, but may readily adapt to living outdoors year-round in USDA hardiness zones 6 through 11 (with some growers having success in zones as low as 4 or 5); the higher the zone's number, the greater the adaptability of the plants. In the growing season (from April to September in the northern hemisphere), the average daytime temperature needed is 23 to 27 °C (73 to 81 °F). In regions with low light levels in winter, the sacred lotus has a period of dormancy. The tubers are not cold-resistant if removed from water and exposed to the air; but when kept underwater in soil, the energy-rich tubers can overwinter temperatures below 0 °C (32 °F). If the plants are taken out of the water for wintertime storage (mostly in exceptionally cold climates), the tubers and roots must be stored in a stable, frost-free location, such as a garage, preferably in a cardboard box or container filled completely with vermiculite or perlite. Care must be taken to fully insulate the tubers.
Sources: en.wikipedia.org
22 January to 18 March The U.S. 3rd Marine Division launched Operation Dewey Canyon to attack People's Army of Vietnam (PAVN) base areas in the A Shau and Song Đa Krông Valleys of Quảng Trị Province. The operation results in 1,617 PAVN killed while 130 Marines were killed.
Registered nurse (RN) Doctor of Nursing Practice (DNP) Master of Science in Nursing (MSN) Bachelor of Science in Nursing (BSN) Associate of Science in Nursing (ASN) Diploma in Nursing Practical nurse (PN, LPN, VN) Certified anesthesiologist assistant (CAA)
Glycobiology is the study of the structure and function of carbohydrates. While DNA, RNA, and proteins are encoded at the genetic level, carbohydrates are not encoded directly from the genome, and thus require different tools for their study. By applying chemical principles to glycobiology, novel methods for analyzing and synthesizing carbohydrates can be developed. For example, cells can be supplied with synthetic variants of natural sugars to probe their function. Carolyn Bertozzi's research group has developed methods for site-specifically reacting molecules at the surface of cells via synthetic sugars.
Benzodiazepines such as diazepam are lipophilic and rapidly penetrate membranes, thus rapidly cross over into the placenta with significant uptake of the drug. Use of benzodiazepines, including diazepam in late pregnancy, especially high doses, can result in floppy infant syndrome. Diazepam when taken late in pregnancy, during the third trimester, causes a definite risk of a severe benzodiazepine withdrawal syndrome in the neonate with symptoms including hypotonia, and reluctance to suck, to apnoeic spells, cyanosis, and impaired metabolic responses to cold stress. Floppy infant syndrome and sedation in the newborn may also occur. Symptoms of floppy infant syndrome and the neonatal benzodiazepine withdrawal syndrome have been reported to persist from hours to months after birth.
== Spectrum of Activity == Oritavancin is active against gram-positive aerobic bacteria such as enterococci, staphylococci, streptococci, and anaerobic bacteria such as Clostridioides difficile, Clostridium perfringens, Peptostreptococcus spp., and Cutibacterium acnes. Oritavancin's spectrum of activity shows similarities to vancomycin, but with lower minimum inhibitory concentrations (MIC).
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.